Figure 3.
Integrated clinical diagnostic system. Illustrated is the concept of how a biodosimetry architecture might be utilised at various times, locations and stages following an incident. Details of the specific components are in NIME(1) with this overall system and some of the components in development while others, such as novel molecular diagnostics, are in research laboratories.